The STARcuff, which is made up of STAR Biomaterial, is designed for the treatment of catheter-associated infections caused while performing hemodialysis procedures.
Healionics chief technology officer and research project principal investigator Andrew Marshall said catheters loaded with active antimicrobial agents or antiseptics are a controversial option for chronic dialysis patients due to the serious threat of microbial resistance.
"STARcuff is an attractive approach because it can potentially provide long-term protection against infection without any active agents," Marshall added.
